Lexaria Bioscience (LEXX) EBITDA Margin (QoQ) (2018 - 2025)
Lexaria Bioscience (LEXX) EBITDA Margin (QoQ) (2018 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Lexaria Bioscience |
7.17 Mn |
1.65 Mn |
20,000.00 |
| Date | Value |
|---|
| Aug 31, 2025 |
61,311.00 |
| May 31, 2025 |
-54,221.00 |
| Feb 28, 2025 |
-14,232.00 |
| Nov 30, 2024 |
112,676.00 |
| Aug 31, 2024 |
-47,596.00 |
| May 31, 2024 |
-165,734.00 |
| Feb 29, 2024 |
31,149.00 |
| Nov 30, 2023 |
325,480.00 |
| Aug 31, 2023 |
-97,963.00 |
| May 31, 2023 |
343,070.00 |
| Feb 28, 2023 |
-468,591.00 |
| Nov 30, 2022 |
-127,609.00 |
| Aug 31, 2022 |
190,465.00 |
| May 31, 2022 |
230,130.00 |
| Feb 28, 2022 |
970,781.00 |
| Nov 30, 2021 |
-1.44 Mn |
| Aug 31, 2021 |
122,344.00 |
| May 31, 2021 |
-68,338.00 |
| Feb 28, 2021 |
-40,333.00 |
| Nov 30, 2020 |
114,580.00 |
